ID   HDAC4_RAT               Reviewed;        1077 AA.
AC   Q99P99;
DT   20-MAR-2007, integrated into UniProtKB/Swiss-Prot.
DT   20-MAR-2007, sequence version 2.
DT   02-OCT-2024, entry version 143.
DE   RecName: Full=Histone deacetylase 4 {ECO:0000250|UniProtKB:P56524};
DE            Short=HD4;
DE            EC=3.5.1.98 {ECO:0000250|UniProtKB:P56524};
GN   Name=Hdac4;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 55-208.
RC   STRAIN=Wistar; TISSUE=Testis;
RA   Wilquet V., Chavez M., Korbers R., Geerts A.;
RT   "Expression pattern of rat histone deacetylases.";
RL   Submitted (NOV-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   INTERACTION WITH BTBD14B.
RX   PubMed=16033423; DOI=10.1111/j.1471-4159.2005.03206.x;
RA   Korutla L., Wang P.J., Mackler S.A.;
RT   "The POZ/BTB protein NAC1 interacts with two different histone deacetylases
RT   in neuronal-like cultures.";
RL   J. Neurochem. 94:786-793(2005).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-563 AND SER-630, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Responsible for the deacetylation of lysine residues on the
CC       N-terminal part of the core histones (H2A, H2B, H3 and H4). Histone
CC       deacetylation gives a tag for epigenetic repression and plays an
CC       important role in transcriptional regulation, cell cycle progression
CC       and developmental events. Histone deacetylases act via the formation of
CC       large multiprotein complexes. Involved in muscle maturation via its
CC       interaction with the myocyte enhancer factors such as MEF2A, MEF2C and
CC       MEF2D. Deacetylates HSPA1A and HSPA1B at 'Lys-77' leading to their
CC       preferential binding to co-chaperone STUB1.
CC       {ECO:0000250|UniProtKB:P56524}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + N(6)-acetyl-L-lysyl-[histone] = acetate + L-lysyl-
CC         [histone]; Xref=Rhea:RHEA:58196, Rhea:RHEA-COMP:9845, Rhea:RHEA-
CC         COMP:11338, ChEBI:CHEBI:15377, ChEBI:CHEBI:29969, ChEBI:CHEBI:30089,
CC         ChEBI:CHEBI:61930; EC=3.5.1.98;
CC         Evidence={ECO:0000250|UniProtKB:P56524};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:58197;
CC         Evidence={ECO:0000250|UniProtKB:P56524};
CC   -!- SUBUNIT: Homodimer. Homodimerization via its N-terminal domain.
CC       Interacts with HDAC7. Interacts with MEF2A, MEF2C, MEF2D, MORC2 and
CC       NR2C1. Interacts with a 14-3-3 chaperone proteins in a phosphorylation
CC       dependent manner. Interacts with 14-3-3 protein YWHAB (By similarity).
CC       Interacts with KDM5B and AHRR (By similarity). Interacts with BTBD14B
CC       (PubMed:16033423). Interacts with MYOCD. Interacts (via PxLPxI/L motif)
CC       with ANKRA2 (via ankyrin repeats). Interacts with CUL7 (as part of the
CC       3M complex); negatively regulated by ANKRA2. Interacts with EP300 in
CC       the presence of TFAP2C. Interacts with HSPA1A and HSPA1B leading to
CC       their deacetylation at 'Lys-77' (By similarity). Interacts with ZBTB7B;
CC       the interaction allows the recruitment of HDAC4 on CD8 loci for
CC       deacetylation and possible inhibition of CD8 genes expression (By
CC       similarity). Interacts with DHX36 (By similarity). Interacts with SIK3;
CC       this interaction leads to HDAC4 retention in the cytoplasm (By
CC       similarity). {ECO:0000250|UniProtKB:P56524,
CC       ECO:0000250|UniProtKB:Q6NZM9, ECO:0000269|PubMed:16033423}.
CC   -!- SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Note=Shuttles between the
CC       nucleus and the cytoplasm. Upon muscle cells differentiation, it
CC       accumulates in the nuclei of myotubes, suggesting a positive role of
CC       nuclear HDAC4 in muscle differentiation. The export to cytoplasm
CC       depends on the interaction with a 14-3-3 chaperone protein and is due
CC       to its phosphorylation at Ser-245, Ser-466 and Ser-630 by CaMK4 and
CC       SIK1. The nuclear localization probably depends on sumoylation (By
CC       similarity). Interaction with SIK3 leads to HDAC4 retention in the
CC       cytoplasm (By similarity). Interacts with ZNF638 (By similarity).
CC       {ECO:0000250, ECO:0000250|UniProtKB:Q6NZM9}.
CC   -!- DOMAIN: The nuclear export sequence mediates the shuttling between the
CC       nucleus and the cytoplasm. {ECO:0000250}.
CC   -!- DOMAIN: The PxLPxI/L motif mediates interaction with ankyrin repeats of
CC       ANKRA2. {ECO:0000250|UniProtKB:P56524}.
CC   -!- PTM: Phosphorylated by CaMK4 at Ser-245, Ser-466 and Ser-630.
CC       Phosphorylation at other residues by CaMK2D is required for the
CC       interaction with 14-3-3. Phosphorylation at Ser-349, within the
CC       PxLPxI/L motif, impairs the binding of ANKRA2 but generates a high-
CC       affinity docking site for 14-3-3 (By similarity).
CC       {ECO:0000250|UniProtKB:P56524}.
CC   -!- PTM: Sumoylation on Lys-557 is promoted by the E3 SUMO-protein ligase
CC       RANBP2, and prevented by phosphorylation by CaMK4.
CC   -!- SIMILARITY: Belongs to the histone deacetylase family. HD type 2
CC       subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AABR03067902; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR03068091; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR03070452; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AF321132; AAK11185.1; -; mRNA.
DR   RefSeq; NP_445901.1; NM_053449.1.
DR   AlphaFoldDB; Q99P99; -.
DR   SMR; Q99P99; -.
DR   BioGRID; 264106; 4.
DR   CORUM; Q99P99; -.
DR   STRING; 10116.ENSRNOP00000027622; -.
DR   BindingDB; Q99P99; -.
DR   ChEMBL; CHEMBL2095943; -.
DR   DrugCentral; Q99P99; -.
DR   iPTMnet; Q99P99; -.
DR   PhosphoSitePlus; Q99P99; -.
DR   PaxDb; 10116-ENSRNOP00000027622; -.
DR   GeneID; 363287; -.
DR   KEGG; rno:363287; -.
DR   UCSC; RGD:619979; rat.
DR   AGR; RGD:619979; -.
DR   CTD; 9759; -.
DR   RGD; 619979; Hdac4.
DR   VEuPathDB; HostDB:ENSRNOG00000020372; -.
DR   eggNOG; KOG1343; Eukaryota.
DR   HOGENOM; CLU_006530_2_0_1; -.
DR   InParanoid; Q99P99; -.
DR   OrthoDB; 124800at2759; -.
DR   PhylomeDB; Q99P99; -.
DR   TreeFam; TF106174; -.
DR   Reactome; R-RNO-350054; Notch-HLH transcription pathway.
DR   Reactome; R-RNO-4090294; SUMOylation of intracellular receptors.
DR   Reactome; R-RNO-4551638; SUMOylation of chromatin organization proteins.
DR   Reactome; R-RNO-8951936; RUNX3 regulates p14-ARF.
DR   PRO; PR:Q99P99; -.
DR   Proteomes; UP000002494; Chromosome 9.
DR   Bgee; ENSRNOG00000020372; Expressed in frontal cortex and 19 other cell types or tissues.
DR   GO; GO:0031672; C:A band; IDA:MGI.
DR   GO; GO:0042641; C:actomyosin; ISO:RGD.
DR   GO; GO:0000785; C:chromatin; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0000118; C:histone deacetylase complex; ISO:RGD.
DR   GO; GO:0031594; C:neuromuscular junction; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0032991; C:protein-containing complex; IDA:RGD.
DR   GO; GO:0030017; C:sarcomere; IDA:MGI.
DR   GO; GO:0017053; C:transcription repressor complex; ISO:RGD.
DR   GO; GO:0030018; C:Z disc; IDA:MGI.
DR   GO; GO:0003682; F:chromatin binding; ISO:RGD.
DR   GO; GO:0003677; F:DNA binding; ISO:RGD.
DR   GO; GO:0140297; F:DNA-binding transcription factor binding; ISO:RGD.
DR   GO; GO:0004407; F:histone deacetylase activity; ISO:RGD.
DR   GO; GO:0042826; F:histone deacetylase binding; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0060090; F:molecular adaptor activity; ISO:RGD.
DR   GO; GO:0030955; F:potassium ion binding; ISO:RGD.
DR   GO; GO:1990841; F:promoter-specific chromatin binding; IDA:RGD.
DR   GO; GO:0019901; F:protein kinase binding; ISO:RGD.
DR   GO; GO:0033558; F:protein lysine deacetylase activity; ISO:RGD.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0061629; F:RNA polymerase II-specific DNA-binding transcription factor binding; ISO:RGD.
DR   GO; GO:0019789; F:SUMO transferase activity; ISO:RGD.
DR   GO; GO:0003714; F:transcription corepressor activity; ISO:RGD.
DR   GO; GO:0008270; F:zinc ion binding; ISO:RGD.
DR   GO; GO:0008283; P:cell population proliferation; ISO:RGD.
DR   GO; GO:0071260; P:cellular response to mechanical stimulus; IEP:RGD.
DR   GO; GO:0071374; P:cellular response to parathyroid hormone stimulus; IEP:RGD.
DR   GO; GO:0071356; P:cellular response to tumor necrosis factor; IEP:RGD.
DR   GO; GO:0006338; P:chromatin remodeling; ISO:RGD.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0045814; P:negative regulation of gene expression, epigenetic; ISO:RGD.
DR   GO; GO:0045820; P:negative regulation of glycolytic process; ISO:RGD.
DR   GO; GO:1902894; P:negative regulation of miRNA transcription; ISO:RGD.
DR   GO; GO:0010832; P:negative regulation of myotube differentiation; ISO:RGD.
DR   GO; GO:0045668; P:negative regulation of osteoblast differentiation; ISO:RGD.
DR   GO; GO:0010944; P:negative regulation of transcription by competitive promoter binding; ISO:RGD.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0002076; P:osteoblast development; ISO:RGD.
DR   GO; GO:0001649; P:osteoblast differentiation; ISO:RGD.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0010592; P:positive regulation of lamellipodium assembly; IMP:RGD.
DR   GO; GO:1902437; P:positive regulation of male mating behavior; IMP:RGD.
DR   GO; GO:0043525; P:positive regulation of neuron apoptotic process; IMP:RGD.
DR   GO; GO:0033235; P:positive regulation of protein sumoylation; ISO:RGD.
DR   GO; GO:1903428; P:positive regulation of reactive oxygen species biosynthetic process; IMP:RGD.
DR   GO; GO:0014911; P:positive regulation of smooth muscle cell migration; IMP:RGD.
DR   GO; GO:0048661; P:positive regulation of smooth muscle cell proliferation; IMP:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0010882; P:regulation of cardiac muscle contraction by calcium ion signaling; ISO:RGD.
DR   GO; GO:0048742; P:regulation of skeletal muscle fiber development; ISO:RGD.
DR   GO; GO:1902809; P:regulation of skeletal muscle fiber differentiation; ISO:RGD.
DR   GO; GO:0097305; P:response to alcohol; IEP:RGD.
DR   GO; GO:0014894; P:response to denervation involved in regulation of muscle adaptation; ISO:RGD.
DR   GO; GO:0070555; P:response to interleukin-1; ISO:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IDA:RGD.
DR   GO; GO:0001501; P:skeletal system development; ISO:RGD.
DR   GO; GO:0060337; P:type I interferon-mediated signaling pathway; ISO:RGD.
DR   CDD; cd10162; ClassIIa_HDAC4_Gln-rich-N; 1.
DR   CDD; cd10006; HDAC4; 1.
DR   Gene3D; 6.10.250.1550; -; 1.
DR   Gene3D; 3.40.800.20; Histone deacetylase domain; 1.
DR   InterPro; IPR046949; HDAC4/5/7/9.
DR   InterPro; IPR000286; His_deacetylse.
DR   InterPro; IPR023801; His_deacetylse_dom.
DR   InterPro; IPR037138; His_deacetylse_dom_sf.
DR   InterPro; IPR024643; Hist_deacetylase_Gln_rich_N.
DR   InterPro; IPR023696; Ureohydrolase_dom_sf.
DR   PANTHER; PTHR45364:SF11; HISTONE DEACETYLASE; 1.
DR   PANTHER; PTHR45364; HISTONE DEACETYLASE 9-RELATED; 1.
DR   Pfam; PF12203; HDAC4_Gln; 1.
DR   Pfam; PF00850; Hist_deacetyl; 1.
DR   PIRSF; PIRSF037911; HDAC_II_euk; 1.
DR   PRINTS; PR01270; HDASUPER.
DR   SUPFAM; SSF52768; Arginase/deacetylase; 1.
PE   1: Evidence at protein level;
KW   Chromatin regulator; Coiled coil; Cytoplasm; Hydrolase; Isopeptide bond;
KW   Metal-binding; Nucleus; Phosphoprotein; Reference proteome; Repressor;
KW   Transcription; Transcription regulation; Ubl conjugation; Zinc.
FT   CHAIN           1..1077
FT                   /note="Histone deacetylase 4"
FT                   /id="PRO_0000281034"
FT   REGION          117..312
FT                   /note="Interaction with MEF2A"
FT                   /evidence="ECO:0000250"
FT   REGION          132..167
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          204..225
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          239..327
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          508..530
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          542..582
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          623..646
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          653..1077
FT                   /note="Histone deacetylase"
FT                   /evidence="ECO:0000250"
FT   REGION          1052..1077
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          66..169
FT                   /evidence="ECO:0000255"
FT   MOTIF           348..353
FT                   /note="PxLPxI/L motif; mediates interaction with ANKRA2 and
FT                   14-3-3 proteins"
FT                   /evidence="ECO:0000250|UniProtKB:P56524"
FT   MOTIF           1044..1077
FT                   /note="Nuclear export signal"
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        132..166
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        204..224
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        239..278
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        290..327
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        515..530
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1061..1077
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        796
FT                   /evidence="ECO:0000250"
FT   BINDING         665
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250"
FT   BINDING         667
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250"
FT   BINDING         673
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250"
FT   BINDING         744
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         209
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q6NZM9"
FT   MOD_RES         245
FT                   /note="Phosphoserine; by CaMK4 and SIK1"
FT                   /evidence="ECO:0000250|UniProtKB:P56524"
FT   MOD_RES         349
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P56524"
FT   MOD_RES         466
FT                   /note="Phosphoserine; by CaMK4 and SIK1"
FT                   /evidence="ECO:0000250|UniProtKB:P56524"
FT   MOD_RES         563
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         630
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         631
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P56524"
FT   CROSSLNK        557
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
FT                   /evidence="ECO:0000250"
SQ   SEQUENCE   1077 AA;  118652 MW;  88127299D9962DBA CRC64;
     MSSQSHPDGL SGRDQPVELL NPARVNHMPS TVDVATALPL QVAPAAVPMD LRLDHQFSLP
     LEPALREQQL QQELLALKQK QQIQRQILIA EFQRQHEQLS RQHEAQLHEH IKQQQEMLAM
     KHQQELLEHQ RKLERHRQEQ ELEKQHREQK LQQLKNKEKG KESAVASTEV KMKLQEFVLN
     KKKALAHRNL NHCMSSDPRY WYGKTQHSSL DQSSPPQSGV SASYNHPVLG MYDAKDDFPL
     RKTASEPNLK LRSRLKQKVA ERRSSPLLRR KDGPVATALK KRPLDVTDSA CSSAPGSGPS
     SPNSSSGNVS TENGIAPTVP STPAETSLAH RLVTREGSVA PLPLYTSPSL PNITLGLPAT
     GPAAGAAGQQ DAERLALPAL QQRISLFPGT HLTPYLSTSP LERDGGAAHN PLLQHMVLLE
     QPPTQTPLVT GLGALPLHTQ SLVGADRVSP SIHKLRQHRP LGRTQSAPLP QNAQALQHLV
     IQQQHQQFLE KHKQQFQQQQ LHLSKMISKP SEPPRQPESH PEETEEELRE HQALLDEPYL
     DRLPGQKEPS LAGVQVKQEP IESEEEEVEA TREAEPSQRP ATEQELLFRQ QALLLEQQRI
     HQLRNYQASM EAAGIPVSFG SHRPLSRAQS SPASATFPMS VQEPPTKPRF TTGLVYDTLM
     LKHQCTCGNT NSHPEHAGRI QSIWSRLQET GLRGKCECIR GRKATLEELQ TVHSEAHTLL
     YGTNPLNRQK LDSSLTSVFV RLPCGGVGVD SDTIWNEVHS SGAARLAVGC VVELVFKVAT
     GELKNGFAVV RPPGHHAEES TPMGFCYFNS VAIAAKLLQQ RLNVSKILIV DWDVHHGNGT
     QQAFYNDPNV LYMSLHRYDD GNFFPGSGAP DEVGTGPGVG FNVNMAFTGG LDPPMGDAEY
     LAAFRTVVMP IANEFAPDVV LVSSGFDAVE GHPTPLGGYN LSAKCFGYLT KQLMGLAGGR
     IVLALEGGHD LTAICDASEA CVSALLGNEL EPLPEKVLHQ RPNANAVHSM EKVMGIHSEY
     WRCLQRLSPT VGHSLIEAQK CENEEAETVT AMASLSVGVK PAEKRSEEEP MEEEPPL
//
